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ABSTRACT 16 
Fatty acid composition, including conjugated linoleic acid (CLA) isomers, of the most 17 
relevant beef by-products (brain, heart, kidney, liver, pancreas and tongue) from young 18 
bulls fed distinct silage levels was assessed. Data indicated a large variation on fatty acid 19 
profile and CLA composition among edible by-products. The most abundant fatty acids 20 
were C16:0 (kidney), C18:0 (heart and liver), and C18:1c9 (brain, pancreas and tongue) 21 
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followed by C20:4n-6, except in brain (C22:6n-3 predominates). Brain, as shown by 22 
Principal Components Analysis, presents a distinct fatty acid composition compared to 23 
the other beef by-products analysed. In addition, high silage diet relative to low silage 24 
diet promoted an increase of n-3 PUFA, t11,t13 and t11,c13 CLA in heart, kidney, liver 25 
and pancreas. Overall, data suggested that fatty acid composition, including CLA 26 
isomers, of beef by-products may contribute for their added-value. Nevertheless, from a 27 
nutritional point of view they are recommended only in small amounts as part of a 28 
balanced diet. 29 
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INTRODUCTION 38 
Fatty acid (FA) content and composition of ruminant meat have been the focus of 39 
intensive research due to its impact on human nutrition and health. Notwithstanding the 40 
high concentration of saturated fatty acids (SFA) and trans fatty acids (TFA), which are 41 
associated with the development of several chronic diseases, ruminant edible fats 42 
contribute also with health beneficial nutrients, including n-3 long-chain polyunsaturated 43 
fatty acids (n-3 LC-PUFA) and conjugated linoleic acid (CLA) isomers. The n-3 LC-44 
PUFA, eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, 45 
C22:6n-3) are structural components of phospholipids in animal tissues, particularly in 46 
brain, heart, liver and kidney, and the precursors of eicosanoids with anti-inflammatory 47 
properties (Christie, 2003; Tinoco, 1982). In addition, the cis-9,trans-11 CLA 48 
(C18:2c9,t11) is naturally found at higher proportions in mammalian tissues with a 49 
multitude of biological actions on cancer, body fat, and immune response (Dilzer and 50 
Park, 2012). CLA isomers are produced in ruminant animals through ruminal microbial 51 
biohydrogenation of dietary polyunsaturated fatty acids (PUFA) and endogenously by ∆9 52 
desaturation of trans monoenes in the adipose tissue and mammary gland (Palmquist et 53 
al., 2004; Nuernberg et al., 2005). Beyond genetics, the FA composition of ruminant meat 54 
can be improved through animal nutrition with use of forages and dietary lipids (Scollan 55 
et al., 2006). 56 
Edible animal by-products, in general, are defined as the edible part of carcass fit for 57 
human consumption, which includes internal organs. Even the consumption of organ 58 
meat can be more or less popular around the countries, which depends on the tradition, 59 
culture and religion, edible by-products may be used as value-added and functional 60 
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ingredients in the meat industry (Mora et al., 2014; Nollet and Toldrá, 2011; Toldrá et al., 61 
2012). Moreover, edible meat by-products may provide valuable amounts of essential 62 
amino acids, fatty acids, minerals and vitamins (Aristoy and Toldrá, 2011; Honikel, 63 
2011). However, to our best knowledge, the characterization of FA composition from the 64 
most consumed edible beef by-products is still somewhat scarce (Florek et al., 2012; 65 
Prates et al., 2011). The major aim of the present study was, therefore, to evaluate and 66 
compare the FA composition, including CLA isomeric profile, in the most consumed beef 67 
by-products (brain, heart, kidney, liver, pancreas and tongue) from young Barrosã bulls. 68 
In addition, we also investigated whether there is an organ specific response to different 69 
dietary silage /concentrate levels. 70 
 71 
MATERIALS AND METHODS 72 
Animals and management 73 
Animal trial and the experimental procedures were carried out according to the 74 
recommendations of the Animal Care Committee of National Veterinary Authority 75 
(Direcção-Geral de Veterinária) following the appropriated European Union guidelines 76 
(Directive 86/609/EEC). Nine male bulls from autochthonous Barrosã breed were 77 
randomly assigned to either higher (70% silage/30% concentrate, n=4) or low (30% 78 
silage/70% concentrate, n=5) silage diets, with individual control of feed intake. During 79 
the experiment, animals were individually fed twice a day and had ad libitum access to 80 
water. The proximate and FA compositions of the experimental diets are displayed in 81 
Table 1. Animals were slaughtered at 18 month-old, with approximately 485 ± 31 kg of 82 
live body weight, at the experimental abattoir (UIPA-INIAV, Unidade de Investigação 83 
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em Produção Animal, Instituto Nacional de Investigação Agrária e Veterinária), after 84 
stunning with cartridge-fired captive bolt stunner and exsanguination. Then, carcasses 85 
were suspended from the Achilles tendon and chilled at 10 ºC. The internal organs (brain, 86 
heart, kidney, liver, pancreas and tongue) were collected, vacuum packed and frozen at 87 
−80 °C until analysis.  88 
 89 
Please insert Table 1 here 90 
 91 
Lipid extraction and methylation 92 
Total lipids were extracted, in duplicate, from lyophilized samples (−60 °C and 2.0 hPa; 93 
Edwards High Vacuum International, UK) according to the method of Folch et al. (1957) 94 
modified by Carlson (1985) and gravimetrically measured by weighting the fatty residue 95 
after solvent evaporation.  96 
 97 
Analysis of fatty acid methyl esters 98 
Fatty acid methyl esters (FAME) were prepared from FA through a combined base/acid 99 
methylation method using 0.5 mol/L sodium methoxide in anhydrous methanol (Sigma-100 
Aldrich Ltd., St. Louis, MO, USA) for 30 min at 50 ºC, followed by hydrochloric acid in 101 
methanol (1:1 v/v) for 10 min at 50 ºC (Raes et al., 2001). FAME were extracted with n-102 
hexane and analysed by GC (chromatograph HP 6890; Hewlett–Packard, Avondale, PA, 103 
USA) fitted with a flame ionisation detector (FID). For the separation of FAME was used 104 
a long fused-capillary column (CP-Sil 88 100 m, 0.25 mm i.d., 0.20 µm film thickness; 105 
Chrompack, Varian Inc., Walnut Creek, CA, USA) according to Alves and Bessa (2009). 106 
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Nonadecanoic acid methyl ester (C19:0; Sigma) was added to the samples prior to 107 
methylation as an internal standard. FA identification was based on FAME standard 108 
(FAME mix with 37 components, Supelco, Inc., Bellefonte, PA) and confirmed by 109 
electron impact mass spectrometry using a Shimadzu GC-MS QP2010 Plus (Shimadzu). 110 
Each FA was expressed as g/100 g of total FA.  111 
 112 
Analysis of individual CLA isomers  113 
Geometric and positional CLA isomers were separated by silver ion high performance 114 
liquid chromatography (Ag+-HPLC) using a chromatograph system (Agilent 1100 Series, 115 
Agilent Technologies Inc., Palo Alto, CA, USA) with three columns in series 116 
(ChromSpher 5 Lipids; 250 mm × 4.6 mm i.d., 5 μm particle size; Chrompack, 117 
Bridgewater, NJ, USA) and equipped with a diode array detector (DAD) set to 233 nm 118 
according to Cruz-Hernandez et al. (2006). Commercial standards (c9,t11, t10,c12, 119 
c11,t13, c9,c11 and t9,t11 from Matreya Inc., Pleasant Gap, PA, USA) were used to 120 
identify the individual CLA isomers. Quantitation of CLA isomers was based on their 121 
Ag+-HPLC areas relative to the area of the main isomer c9,t11 determined by GC-FID 122 
(plus t7,c9 and t8,c10 isomers) as described by Kraft et al. (2003). Total CLA was 123 
expressed as gravimetric content (mg/g tissue) and the individual isomers as a percentage 124 
of the sum of CLA isomers (% total CLA). 125 
 126 
Statistical analysis 127 
Data was analyzed using the PROC MIXED and checked for variance heterogeneity 128 
using the software package (SAS, 2009). The statistical model included the feeding effect 129 
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as repeated measure. Data were reported as mean ± standard error (SE). Least squares 130 
means (LSMEANS), with the option PDIFF adjusted with Tukey–Kramer method, were 131 
determined to compare groups. The level of significance was set at P-value below 0.05.  132 
The principal component analysis (PCA) of FA composition and CLA isomers (as a 133 
percentage of total FA) in beef by-products (brain, heart, kidney, liver, pancreas and 134 
tongue) were carried out using the STATISTICA software (StatSoft, Inc., 2004).  135 
 136 
RESULTS AND DISCUSSION 137 
Fatty acid composition 138 
Total lipids of some edible by-products (brain, heart, kidney, liver, pancreas and tongue) 139 
from Barrosã bulls fed HS or LS diets are shown in Tables 2 and 3. Total lipids were 140 
higher in brain (6.8-7.0%), intermediate in pancreas (3.8-4.0%), tongue (2.9-3.6%) and 141 
liver (2.7%) and lower in kidney and heart (2.1% and 1.7%, respectively), although no 142 
differences were found between feeding strategies (P>0.05). The contents of total lipids 143 
in beef by-products were comparable to lean meat (<5%), except in brain. However, these 144 
results were relatively lower than those reported by Honikel (2011) for the same by-145 
products, probably, due to differences in breed, gender, age and feeding regimens. 146 
Indeed, breed and diet are the main factors influencing lipid content and composition.  147 
The cholesterol content (mg/100 g tissue) in edible by-products from Barrosã bulls is 148 
presented in Tables 2 and 3. Diet had no effect on cholesterol levels of beef-products. 149 
Total cholesterol was higher in brain (1640-2075 mg/100 g) of Barrosã bulls from both 150 
feeding regimens when compared to the remaining organs. Similar cholesterol levels in 151 
beef brain (1456-3010 mg/100 g) were reported elsewhere (Mustafa, 1988; USDA, 152 
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2009). In addition, our results of cholesterol contents in kidney (304-309 mg/100 g), liver 153 
(154-158 mg/100 g) and heart (99-102 mg/100 g) agree with those found by Bragagnolo 154 
(2011) in beef kidney (100-517 mg/100 g), liver (159-162 mg/100 g) and heart (72-150 155 
mg/100 g). It has long been known that cholesterol plays an important role for body 156 
function, as a main lipid constituent of the cell membranes and the precursor of steroid 157 
hormones, vitamins and bile acids. Cholesterol can be synthesized endogenously, within 158 
the liver and intestines, and obtained from the diet by animal-derived products. Yet, high 159 
serum cholesterol levels have been associated with an increased risk of chronic diseases, 160 
whereby the recommended maximum cholesterol intake should be less than 300 mg per 161 
day (American Heart Association, 2008). Regarding cholesterol in organ meats, the 162 
values of cholesterol can increase 3- to 5-fold up than in lean meat (Bragagnolo, 2011).  163 
The FA composition (g/100 g of total FA), partial sums and ratios of FA in beef by-164 
products (brain, heart, kidney, liver, pancreas and tongue) from bulls fed HS or LS diets 165 
are also presented in Tables 2 and 3. The most representative FA in beef by-products 166 
were C18:1c9 (9–36% of total FAME), C18:0 (11–32 %) and C16:0 (8–22%). Our 167 
research group has previously found a similar FA pattern in meat from Barrosã bulls 168 
(Costa et al., 2013). Nevertheless, the order of appearance of the FA detected in beef by-169 
products was quite different. The main LC-PUFA in beef by-products was arachidonic 170 
acid (ARA, 20:4n-6), except in brain where DHA (7%) and ARA (6%) predominates. 171 
These data are in agreement with the study of Cordain et al. (2002), who also reported 172 
higher DHA levels in brain of wild ruminant animals (8.9% in elk, 9.2% in antelope and 173 
9.6% in deer) compared to other internal organs. DHA, EPA and ARA can be synthesized 174 
by a series of reactions involving Δ6 desaturation, elongation and Δ5 desaturation from the 175 
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precursors substrates α-linolenic acid (C18:3n-3, ALA) and linoleic acid (C18:2n-6, LA), 176 
respectively (Burdge and Calder, 2005). Thus, the conversion of these essential fatty 177 
acids (ALA and LA) into more desaturated FA depends on the type of dietary PUFA 178 
(Harnack et al., 2009). Diet influenced the percentages of minor FA in beef by-products, 179 
except in brain. Bulls fed the HS diet had higher percentages of a-C15:0 (P<0.05), C15:0 180 
(P<0.01), i-C16:0 (P<0.05), i-C17:0 (P<0.05), a-C17:0 (P<0.001), C17:0 (P<0.05), 181 
C20:0 (P<0.05), C18:3n-3 (P<0.01) and C20:5n-3 (P<0.05) in heart than those fed the LS 182 
diet. Moreover, the HS diet promoted the deposition of C14:1c9 (P<0.01), i-C15:0 183 
(P<0.05), i-C16:0 (P<0.01), i-C17:0 (P<0.01), C18:3n-3, C20:5n-3 and C22:5n-3 184 
(P<0.05) in kidney when compared to the LS diet. Only the proportion of C18:1c13 185 
(P<0.05) was higher in the LS diet. A similar FA pattern was observed in pancreas, 186 
except for C20:5n-3 and C22:5n-3 (P>0.05). Barrosã bulls fed the HS diet had the highest 187 
percentages of C15:0, C18:3n-3 and C22:5n-3 in liver whereas the percentages of DMA-188 
C18:1, C18:1t9, C18:1t10 and C18:1c13 in those fed the LS diet. Feeding the HS diet 189 
also promoted higher percentages of minor FA in tongue (i-C15:0 (P<0.01), a-C15:0 190 
(P<0.05), i-C16:0 (P<0.05), i-C17:0 (P<0.01), a-C17:0 (P<0.01), C18:1c14+t16 191 
(P<0.05) and C18:3n-3 (P<0.05)) compared to LS diet.  192 
The pattern obtained for the partial sums of FA (Tables 2 and 3) reflected the values 193 
described for individual FA. Besides genetic and nutritional factors, the fatty acid 194 
composition depends largely on the fat level and tissue (Wood et al., 2008). Pancreas and 195 
liver of Barrosã bulls had higher SFA and lower monounsaturated fatty acids (MUFA) 196 
percentages. In contrast, tongue presented higher MUFA and lower SFA percentages. 197 
However, no differential response to dietary silage level was detected for SFA and 198 
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MUFA contents (P>0.05). These results are in line with those reported by Florek et al. 199 
(2012), who observed distinctly higher SFA and MUFA percentages in offal of veal 200 
calves and suckler beef. The former authors found that liver presented the highest SFA 201 
and the lowest MUFA, and consequently the lowest SFA/MUFA ratio, while tongue 202 
showed the highest percentage of MUFA. Beef by-products, with exception of heart, are 203 
relatively saturated mainly due to the percentages of C16:0 and C18:0 (and C18:1c9), 204 
which suggest a strong contribution of de novo synthesis of FA in these tissues. The 205 
different rates of de novo FA biosynthesis have been ascribed to the activity of lipogenic 206 
enzymes. Steroyl-CoA desaturase (SCD) is a rate-limiting enzyme that catalyzes the 207 
MUFA biosynthesis, and therefore, with a specific role in lipid deposition (Taniguchi et 208 
al., 2004). In contrast to SFA and MUFA, the content of TFA in beef by-products is very 209 
low (ranging from 2-6% of the total FA) with vaccenic acid (C18:1t11) predominating, 210 
except in brain. However, feeding the LS diet, rich in starch, promoted the deposition of 211 
C18:1t10 in liver of Barrosã bulls in comparison to the HS diet (P<0.05). It has been 212 
suggested that the use of concentrate in ruminant diets induces changes in the rumen 213 
microbiota, which tend to shift the pattern of major biohydrogenation intermediates 214 
(C18:1t11 and CLA isomers) towards C18:1t10 production (Bessa et al., 2015; Glasser et 215 
al., 2008; Griinari and Bauman, 1999). Relatively to PUFA, as expected, heart (41%) 216 
kidney (38%) and liver (35%) had the highest proportions of these FA due to the lowest 217 
values of total lipids, although no variation between diets was observed (P>0.05). In 218 
general, the PUFA percentages of the n-3 family were relatively low in the beef by-219 
products analysed, except in brain. These results are consistent with those described by 220 
Prates et al. (2011) for beef and pork by-products. Moreover, the HS diet (rich in C18:3n-221 
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3) promoted higher n-3 PUFA percentages in liver, heart and kidney in comparison to the 222 
LS diet (P<0.01). Finally, the proportions of dimethylacetals (DMA) in beef by-products 223 
varied greatly contributing for total FA with 1-3% in pancreas, liver, tongue and kidney, 224 
6-8% in brain and 11-13% in heart. In addition, Pérez-Palacios et al. (2007) have shown 225 
that DMA may be influenced by dietary FA composition. In the present study, the 226 
proportions of DMA in the beef by-products analysed were unaffected by diets (P>0.05) 227 
but, in contrast to our data, Aldai and co-workers (2011) found higher proportions of 228 
DMA in ruminant meat promoted by HS diet. Minor proportions of iso- and anteiso- of 229 
branched chain fatty acids (BCFA) were found in beef by-products. While feeding HS or 230 
LS diets had no influence on BCFA of brain and liver (P>0.05), the HS diet promoted the 231 
deposition of BCFA in heart (P<0.001), kidney and tongue (P<0.01) and pancreas 232 
(P<0.05) in comparison to the LS diet.  233 
The FA ratios of beef by-products from Barrosã bulls fed HS or LS diets are also 234 
presented on Tables 2 and 3. According to nutritional guidelines, the PUFA/SFA ratio in 235 
the human diet should be above 0.45 and the n-6/n-3 ratio should not exceed 4.0 236 
(Department of Health, 1994). The PUFA/SFA ratios in beef by-products were within the 237 
recommended values, except in pancreas and tongue. Florek et al. (2012) found similar 238 
PUFA/SFA ratios in offal from suckler beef and veal calves, however, the values were 239 
higher in offal from suckler beef compared with those from veal calves. In ruminants, a 240 
large amount of dietary PUFA is biohydrogenated by rumen microorganisms into high 241 
levels of SFA available for deposition in muscle tissue, and the net result is a lower 242 
PUFA/SFA ratio. Diet did not affect the PUFA/SFA ratio (P>0.05). Raes et al. (2004) 243 
suggested that the ratio between PUFA and SFA fatty acids is mainly influenced by 244 
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genetics rather than nutrition. In contrast, the n-6/n-3 ratios were above the recommended 245 
values in all beef by-products. The values of n-6/n-3 ratios were higher in heart (16-22), 246 
intermediate in pancreas and tongue (8-13) and lower in brain and liver (1-6). Moreover, 247 
the n-6/n-3 ratio was consistently higher in LS diet compared to those from HS diet 248 
(P<0.05), except in brain. It has been shown that the use of cereals-based diets (poor in n-249 
3 FA) changes the FA composition creating an unfavourable n-6/n-3 FA ratio (Garcia et 250 
al., 2008: Wood et al., 2008). 251 
 252 
Please insert Tables 2 and 3 here 253 
  254 
CLA isomeric profile 255 
Total CLA content (mg/100 g tissue) and CLA isomeric profile (% of total CLA) of beef 256 
by-products are displayed in Table 4. Pancreas (10.9-11.6), tongue (11.9-15.1), kidney 257 
(10.5) and liver (9.3-9.4) of Barrosã bulls showed the highest values of total CLA 258 
whereas brain (1.2-1.6) and heart (2.4-2.6) the lowest ones. However, no differential 259 
response to dietary silage level was observed for total CLA (P>0.05). The large variation 260 
in total CLA contents among beef by-products may be explained by the distinct 261 
concentration of triacylglycerols in these tissues. Florek et al. (2012) also found high 262 
contents of CLA (C18:2c9t11/t10c12) in offal from veal calves (liver > tongue > heart > 263 
kidney). CLA contents vary substantially between species as well as from animal to 264 
animal and within different tissues (Prates and Bessa, 2009; Schmid et al., 2006). The 265 
major CLA isomer (c9,t11) as well as the usually second most prevalent isomer (t7,c9) 266 
are mainly produced in the tissues through ∆9 desaturation of trans C18:1 and in the 267 
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rumen during microbial biohydrogenation of dietary C18 PUFA (Griinari and Bauman, 268 
1999; Palmquist et al., 2004; Prates and Bessa, 2009). Even though the major dietary 269 
sources of CLA are ruminant-derived products, the levels of intake remain to be 270 
established. It has been recommended a daily intake of 0.8-3.0 g/day based on the anti-271 
cancer effects of CLA (Parish et al., 2003; Schmid et al., 2006). Specific physiological 272 
effects have been linked to CLA isomers, the t10,c12 CLA isomer may play an important 273 
role in lipid metabolism, while the c9,t11 and the t10,c12 isomers seem to be equally 274 
effective in anticarcinogenesis (Pariza et al., 2001). 275 
The most abundant CLA isomer in beef by-products was, as in ruminant meat, the 276 
c9,t11 isomer (62-84% of total CLA) followed by t7,c9 (3.5-6.3%), except in brain. 277 
t11,c13 (20%) was the second predominant isomer in brain. As far as we know, this 278 
preferential deposition of t11,c13 CLA in brain remains to be established (Prates et al., 279 
2011). The t10,c12 CLA isomer was only residual in beef by-products. In addition,, 280 
c9,t11 was more accumulated (84%) in liver and kidney while the t10,c12 was relatively 281 
incorporated (up to 1%) into heart and tongue. The studies carried out by Kramer et al. 282 
(1998) and Li and Warkins (1998) also reported a preferential accumulation of c9,t11 283 
isomer in liver, serum, bone and marrow and a higher incorporation of the t10,c12 into 284 
spleen, muscle and heart.  285 
Data in Table 4 also shows that bulls fed the HS diet had the highest percentages of 286 
t11,t13 and t11,c13 in heart, kidney, liver and pancreas when compared to those fed the 287 
LS diet. In contrast, feeding the LS diet to Barrosã bulls increases the proportions of 288 
t10,c12 in liver and kidney. CLA composition of ruminant meat has been related to 289 
pasture vs. cereal-based concentrate diet (Alfaia et al, 2009; Raes et al., 2004; Schmid et 290 
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al., 2006). Indeed, meat from grass-fed ruminants have been shown to had highest 291 
proportions of t11,c13, t11,t13, and t12,t14 isomers and lowest percentage of t7,c9 CLA 292 
isomer than meat from ruminants fed on high grain diets (Dannenberger et al., 2005).  293 
 294 
Please insert Table 4 here 295 
 296 
Principal component analysis 297 
The projection of the first (PC1) and second (PC2) components in the plane using the 298 
percentage of FA and CLA isomers determined in the six meat organs (brain, heart, 299 
kidney, liver, pancreas and tongue) is displayed in Fig. 1A. The score plot of the first two 300 
principal components explained 58.2% of the total variance, with 39% for PC1 and 301 
19.2% for PC2 (Table 5). In addition, the pattern in Fig. 1A suggests that PC1 302 
differentiates the FA derived from the endogenous synthesis (positive PC1 loadings) and 303 
PC2 the FA derived from ruminal biohydrogenation (negative PC1 loadings). The PC1 304 
was characterised by variables with positive loadings, such as C20:5n-3 (0.941), DMA-305 
C18:1 (0.901), C22:6n-3 (0.855), C20:1c11 (0.841) and C22:5n-6 (0.836), and by 306 
variables with negative loadings, like a-C17:0 (-0.959), i-C17:0 (-0.897), C18:1t11 (-307 
0.854), C18:1t9 (-0.820), c9,t11 (-0.815) and t7,c9 (-0.781). The PC2 was positively 308 
defined by C18:1c9:0 (0.870), C16:0 (0.852), C18:1c13 (0.799) and C14:0 (0.743), and 309 
negatively by C22:5n-3 (-0.841), C22:0 (-0.823), C20:4n-6 (-0.750), C18:3n-3 (-0.714), 310 
C18:0 (-0.657), C18:2n-6 (-0.634) and t11,t13 (-0.627). However, the score plot from 311 
PC1 × PC2 plane does not discriminates between HS and LS treatments (both C18:2n-6 312 
and C18:3n-3 formed a cluster in quadrant d). 313 
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In addition, projection of scores of the first two PCs (Figure 1B) was arranged in four 314 
clusters, corresponding to the six organs. Tongue and pancreas were located in quadrant 315 
a, brain in quadrant b, heart in quadrant c, liver in quadrant d and heart was dispersed 316 
across all quadrants. Summing up, it is important to notice a clear separation of brain 317 
from the remaining organs, which may contribute the highest percentages of DHA in this 318 
tissue.  319 
 320 
Please insert Table 5 and Figure 1 here 321 
 322 
CONCLUSIONS 323 
Beef by-products (brain, heart, kidney, liver, pancreas and tongue) from bulls fed HS and 324 
LS diets had, in general, higher contents of cholesterol, SFA, and TFA, as well as high 325 
levels of CLA. The major FA in beef by-products were oleic acid, stearic and palmitic 326 
acids, as well as arachidonic acid, except in brain. FA composition of brain, compared to 327 
the other internal organs, presented higher n-3 LC-PUFA, particularly DHA. In addition, 328 
heart, kidney, liver and pancreas of bulls fed HS diet, compared to those from bulls fed 329 
LS diet, had the most favourable FA profile, specially greater proportions of n-3 PUFA, 330 
and t11,t13 and t11,c13 CLA isomers, as a result of the beneficial effects of grass silage. 331 
Based on these nutritional characteristics, it is recommended to consume these beef by-332 
products in small amounts and integrated in a balanced diet.  333 
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FIGURE CAPTION 475 
Figure 1. Loading plot of the first (PC1) and second (PC2) principal components of the 476 
pooled data (A) and components score vectors (B) for the beef by-products (brain, heart, 477 
kidney, liver, pancreas and tongue). 478 
479 
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Table 1. Composition of the experimental diets. 480 
 
HS LS 
Proximate composition (%DM)   
Crude protein  14.2 12.5 
Crude fat  2.87 3.17 
Crude fibre  19.8 15.0 
NDF  40.3 32.1 
ADF  24.9 18.6 
Ash  5.53 6.17 
Starch  28.5 37.6 
Gross energy (MJ/kg DM) 19.1 18.6 
Fatty acid composition (mg/g DM)   
C16:0 16.1 16.5 
C18:0 4.05 6.33 
C20:0 5.22 2.61 
C18:1c9 12.1 11.0 
C18:2n-6 35.1 28.2 
C18:3n-3 7.36 4.21 
HS, silage diet based on 30/70% of concentrate and silage, respectively (n = 3); LS, low 481 
silage diet based on 70/30% of concentrate and silage, respectively (n = 3); DM = dry 482 
matter; NDF = neutral detergent fibre; ADF = acid detergent fibre. 483 
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Table 2. Total lipids (%), total cholesterol (mg/100 g) and fatty acid composition (g/100 g total fatty acids) of beef brain, heart and kidney from Barrosã bulls fed high (HS) or low 484 
silage (LS) diets. 485 
  Brain  Heart  Kidney 
 HS  LS   HS  LS   HS  LS  
 Mean SE  Mean SE P value  Mean SE  Mean SE P value  Mean SE  Mean SE P value 
Total lipids 6.98 0.626  6.84 0.463 ns  1.63 0.175  1.70 0.141 ns  2.09 0.191  2.06 0.131 ns 
Total cholesterol 2075 339  1640 292 ns  102 1.94  99.0 1.30 ns  304 7.03  309 4.12 ns 
Fatty acid composition                    
C14:0 0.53 0.009  0.53 0.023 ns  0.44 0.075  0.40 0.051 ns  0.46 0.032  0.48 0.032 ns 
C14:1c9 0.14 0.011  0.12 0.011 ns  0.27 0.016  0.22 0.013 ns  0.25 0.013  0.17 0.013 ** 
i-C15:0 nd nd  nd nd -  0.07 0.004  0.06 0.004 ns  0.16 0.013  0.12 0.002 * 
a-C15:0 nd nd  nd nd -  0.19 0.017  0.11 0.011 *  0.11 0.008  0.08 0.010 ns 
C15:0 0.12 0.011  0.13 0.007 ns  0.25 0.008  0.17 0.014 **  0.42 0.021  0.35 0.021 ns 
DMA-C16:0 2.36 0.403  2.90 0.253 ns  6.71 0.332  8.29 0.204 **  2.53 0.116  2.43 0.107 ns 
i-C16:0 0.05 0.007  0.04 0.007 ns  0.16 0.017  0.08 0.008 *  0.21 0.009  0.12 0.015 ** 
C16:0 16.1 0.386  16.0 0.248 ns  11.3 0.412  10.8 0.173 ns  15.7 0.369  15.8 0.207 ns 
C16:1 0.11 0.008  0.10 0.005 ns  0.08 0.008  0.08 0.013 ns  0.23 0.036  0.21 0.040 ns 
i-C17:0 nd nd  nd nd -  0.28 0.003  0.21 0.010 **  0.33 0.014  0.26 0.011 ** 
C16:1c7 0.47 0.008  0.50 0.021 ns  0.11 0.011  0.11 0.011 ns  0.42 0.021  0.41 0.022 ns 
C16:1c9 0.33 0.011  0.35 0.007 ns  0.48 0.094  0.55 0.059 ns  0.77 0.063  0.95 0.111 ns 
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a-C17:0 nd nd  nd nd -  0.32 0.008  0.25 0.005 ***  0.45 0.022  0.38 0.013 ns 
C17:0 0.43 0.016  0.44 0.011 ns  0.48 0.030  0.39 0.024 *  0.66 0.019  0.63 0.021 ns 
DMA-C18:0 2.55 0.433  3.26 0.250 ns  4.14 0.259  3.76 0.143 ns  0.78 0.052  0.67 0.043 ns 
DMA-C18:1 1.37 0.245  1.71 0.135 ns  0.53 0.032  0.61 0.032 ns  0.12 0.017  0.13 0.010 ns 
C18:0 17.5 0.569  16.8 0.368 ns  15.5 0.419  13.9 0.230 *  12.9 0.115  12.4 0.245 ns 
C18:1t6+t8 0.03 0.001  0.04 0.008 ns  0.09 0.011  0.07 0.006 ns  0.15 0.019  0.13 0.006 ns 
C18:1t9 0.04 0.004  0.05 0.004 ns  0.09 0.007  0.07 0.006 ns  0.13 0.023  0.12 0.007 ns 
C18:1t10 0.07 0.004  0.06 0.014 ns  0.09 0.011  0.11 0.019 ns  0.13 0.034  0.16 0.022 ns 
C18:1t11 0.04 0.005  0.05 0.002 ns  0.79 0.130  0.62 0.058 ns  0.57 0.096  0.59 0.057 ns 
C18:1t12 0.39 0.008  0.40 0.016 ns  0.19 0.020  0.16 0.010 ns  0.28 0.021  0.30 0.020 ns 
C18:1c9 20.5 0.418  20.2 0.404 ns  9.33 1.112  8.83 0.757 ns  15.5 0.443  16.1 0.505 ns 
C18:1c11+t15 4.61 0.123  4.39 0.048 ns  1.99 0.025  2.29 0.176 ns  3.13 0.117  3.63 0.213 ns 
C18:1c12 0.45 0.107  0.35 0.037 ns  0.62 0.030  0.62 0.039 ns  0.45 0.064  0.48 0.026 ns 
C18:1c13 0.20 0.019  0.20 0.015 ns  0.08 0.006  0.07 0.003 ns  0.13 0.023  0.23 0.026 * 
C18:1c14+t16 0.07 0.016  0.08 0.010 ns  0.10 0.010  0.08 0.004 ns  0.18 0.024  0.17 0.011 ns 
C18:1c15 nd nd  nd nd -  nd nd  nd nd -  0.08 0.009  0.08 0.004 ns 
C18:2n-6 0.42 0.024  0.42 0.020 ns  27.9 1.515  28.8 0.920 ns  20.5 0.644  20.4 0.754 ns 
C20:0 0.19 0.012  0.20 0.010 ns  0.15 0.011  0.11 0.008 *  0.29 0.012  0.30 0.013 ns 
C18:3n-3 0.11 0.013  0.10 0.006 ns  0.88 0.049  0.57 0.038 **  0.98 0.037  0.82 0.047 * 
C20:1c11 2.22 0.223  2.18 0.044 ns  0.08 0.008  0.10 0.012 ns  0.33 0.022  0.37 0.008 ns 
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C18:2c9t11 0.04 0.006  0.03 0.002 ns  0.17 0.020  0.18 0.020 ns  0.33 0.040  0.42 0.050 ns 
C18:4n-3 0.43 0.026  0.42 0.018 ns  nd nd  nd nd -  nd nd  nd nd - 
C20:2n-6 0.09 0.002  0.09 0.005 ns  0.16 0.013  0.19 0.013 ns  0.55 0.054  0.50 0.032 ns 
C22:0 0.47 0.018  0.42 0.028 ns  1.09 0.151  1.01 0.104 ns  0.82 0.127  0.73 0.053 ns 
C20:3n-6 0.14 0.022  0.17 0.013 ns  0.08 0.008  0.08 0.007 ns  0.09 0.009  0.09 0.010 ns 
C20:3n-3 0.08 0.005  0.09 0.006 ns  nd nd  nd nd -  0.24 0.019  0.19 0.018 ns 
C20:4n-6 6.27 0.159  5.86 0.278 ns  9.91 0.412  11.1 0.433 ns  12.7 0.688  12.8 0.573 ns 
C20:5n-3 nd nd  nd nd -  0.50 0.040  0.37 0.027 *  0.47 0.029  0.34 0.012 * 
C22:4n-6 4.14 0.030  4.12 0.049 ns  0.35 0.010  0.44 0.046 ns  0.66 0.057  0.68 0.027 ns 
C22:5n-6 2.28 0.302  1.95 0.106 ns  0.10 0.012  0.13 0.015 ns  0.13 0.017  0.14 0.024 ns 
C22:5n-3 0.35 0.008  0.36 0.006 ns  0.82 0.028  0.74 0.046 ns  1.28 0.062  1.03 0.042 * 
C22:6n-3 7.40 0.502  7.44 0.458 ns  0.13 0.011  0.14 0.007 ns  0.39 0.051  0.31 0.028 ns 
Others 5.61 0.471  6.29 0.446 ns  3.05 0.149  3.17 0.059 ns  2.99 0.160  3.37 0.073 ns 
Fatty acid partial sums                   
∑ SFA 35.3 0.964  34.4 0.592 ns  29.2 0.926  26.8 0.458 ns  31.4 0.375  30.6 0.307 ns 
∑ cis MUFA 24.4 0.613  23.8 0.452 ns  11.0 1.16  10.5 0.786 ns  17.9 0.582  18.7 0.655 ns 
∑ TFA 5.40 0.158  5.20 0.071 ns  3.58 0.201  3.67 0.163 ns  5.34 0.241  5.80 0.228 ns 
∑ PUFA 23.0 0.773  22.3 0.654 ns  40.8 1.74  42.5 0.929 ns  38.0 0.617  37.2 0.859 ns 
∑ n-6 PUFA 13.3 0.361  12.6 0.296 ns  38.5 1.68  40.7 0.883 ns  34.6 0.529  34.5 0.850 ns 
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∑ n-3 PUFA 9.65 0.437  9.68 0.399 ns  2.33 0.069  1.82 0.078 **  3.37 0.110  2.70 0.062 ** 
∑ n-6 LC-PUFA 12.9 0.347  12.2 0.281 ns  10.6 0.410  11.9 0.473 ns  14.1 0.717  14.2 0.602 ns 
∑ n-3 LC-PUFA 9.12 0.451  9.16 0.426 ns  1.45 0.068  1.25 0.072 ns  2.39 0.114  1.88 0.071 * 
∑ DMA 6.28 1.06  7.87 0.586 ns  11.4 0.559  12.7 0.287 ns  3.43 0.178  3.23 0.150 ns 
∑ BCFA 0.07 0.013  0.02 0.014 ns  1.02 0.031  0.72 0.019 ***  1.25 0.046  0.97 0.036 ** 
Fatty acid ratios                    
PUFA/SFA 0.65 0.007  0.65 0.009 ns  1.41 0.108  1.59 0.060 ns  1.21 0.025  1.22 0.032 ns 
n-6/n-3 1.38 0.036  1.31 0.040 ns  16.5 0.370  22.5 0.869 **  10.3 0.241  12.8 0.343 *** 
Data are means ± standard error (SE). SFA = ∑ C14:0, C16:0, C18:0, C20:0 and C22:0; cis MUFA = ∑ C14:1c9, C16:1c7, C16:1c9, C18:1c9, C18:1c12, C18:1c13, C18:1c15 and C20:1c11; TFA = ∑ 486 
C18:1t6+t8-, C18:1t9, C18:1t10, C18:1t11, C18:1c11+t15, C18:1t12, C18:1c14+t16 and C18:2c9t11; PUFA = ∑ C18:2n-6, C18:3n-3, C18:4n-3, C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C20:5n-3, 487 
C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3; n-6 PUFA = ∑ C18:2n-6, C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C22:4n-6 and C22:5n-6; n-3 PUFA = ∑ C18:3n-3, C18:4n-3, C20:3n-3, C20:5n-3, 488 
C22:5n-3 and C22:6n-3; n-6 LC-PUFA = n-6 long chain-PUFA = ∑ C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C22:4n-6 and C22:5n-6; n-3 LC-PUFA = n-3 long chain-PUFA = ∑ C20:3n-3, C20:5n-489 
3, C22:5n-3 and C22:6n-3; DMA = dimethylacetals = ∑ DMA-C16:0, DMA-C18:0 and DMA-C18:1; BCFA = branched chain fatty acids = ∑ i-C15:0, a-C15:0, i-C16:0, i-C17:0 and a-C17:0. 490 
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Table 3. Total lipids (%), total cholesterol (mg/100 g tissue), total fatty acids (g/100 g tissue) and composition (g/100 g total fatty acids) of beef liver, pancreas and tongue from 491 
Barrosã bulls fed high (HS) or low silage (LS) diets. 492 
 493 
 Liver  Pancreas  Tongue 
 HS  LS   HS  LS   HS  LS  
 Mean SE  Mean SE P value  Mean SE  Mean SE P value  Mean SE  Mean SE P value 
Total lipids 2.66 0.286  2.62 0.200 ns  3.77 0.226  4.03 0.202 ns  3.59 0.750  2.89 0.335 ns 
Total cholesterol 154 10.2  158 2.47 ns  157 7.69  153 3.92 ns  65.6 3.98  68.1 2.37 ns 
Fatty acid composition                    
C14:0 0.30 0.025  0.33 0.065 ns  1.68 0.187  1.59 0.098 ns  2.59 0.329  2.62 0.067 ns 
C14:1c9 0.25 0.026  0.15 0.033 ns  0.13 0.014  0.14 0.013 ns  0.76 0.096  0.83 0.039 ns 
i-C15:0 0.13 0.013  0.09 0.012 ns  0.18 0.018  0.11 0.009 *  0.11 0.007  0.07 0.002 ** 
a-C15:0 0.14 0.016  0.11 0.014 ns  0.22 0.030  0.14 0.016 ns  0.15 0.018  0.09 0.002 * 
C15:0 0.23 0.017  0.18 0.011 *  0.47 0.052  0.34 0.047 ns  0.39 0.021  0.34 0.025 ns 
DMA-C16:0 0.91 0.078  1.06 0.127 ns  0.71 0.144  0.89 0.097 ns  1.54 0.476  1.67 0.260 ns 
i-C16:0 0.14 0.019  0.11 0.012 ns  0.32 0.036  0.16 0.014 *  0.22 0.035  0.10 0.012 * 
C16:0 8.51 0.338  8.83 1.01 ns  21.6 0.455  21.6 0.630 ns  18.9 1.43  19.7 0.568 ns 
C16:1 0.08 0.012  0.08 0.007 ns  0.09 0.015  0.10 0.007 ns  0.06 0.005  0.06 0.007 ns 
i-C17:0 0.23 0.022  0.19 0.010 ns  0.49 0.018  0.36 0.019 **  0.36 0.009  0.27 0.012 ** 
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C16:1c7 0.18 0.006  0.21 0.019 ns  0.30 0.017  0.29 0.015 ns  0.32 0.012  0.32 0.014 ns 
C16:1c9 0.53 0.048  0.68 0.152 ns  1.77 0.074  2.45 0.276 ns  3.74 0.363  4.46 0.330 ns 
a-C17:0 0.42 0.056  0.38 0.021 ns  0.72 0.049  0.64 0.032 ns  0.67 0.022  0.53 0.022 ** 
C17:0 1.03 0.079  0.92 0.066 ns  0.91 0.079  0.68 0.057 ns  0.82 0.061  0.76 0.043 ns 
DMA-C18:0 0.33 0.028  0.30 0.012 ns  0.26 0.057  0.26 0.035 ns  1.07 0.361  0.81 0.124 ns 
DMA-C18:1 0.05 0.005  0.07 0.007 *  0.14 0.031  0.14 0.025 ns  0.06 0.015  0.08 0.020 ns 
C18:0 31.5 0.367  31.3 0.710 ns  20.0 1.67  16.6 1.25 ns  13.1 0.591  11.2 0.443 ns 
C18:1t6+t8 0.07 0.005  0.08 0.006 ns  0.31 0.018  0.29 0.024 ns  0.14 0.013  0.12 0.008 ns 
C18:1t9 0.07 0.007  0.09 0.005 *  0.18 0.018  0.18 0.011 ns  0.21 0.015  0.19 0.011 ns 
C18:1t10 0.08 0.004  0.16 0.019 *  0.24 0.023  0.33 0.048 ns  0.19 0.024  0.23 0.019 ns 
C18:1t11 0.94 0.111  1.12 0.131 ns  1.37 0.133  1.09 0.142 ns  1.01 0.135  0.76 0.085 ns 
C18:1t12 0.41 0.029  0.46 0.016 ns  0.22 0.019  0.24 0.019 ns  0.19 0.027  0.16 0.019 ns 
C18:1c9 10.6 0.236  11.3 1.28 ns  27.3 0.655  28.9 1.41 ns  34.4 1.75  35.6 0.942 ns 
C18:1c11+t15 1.13 0.053  1.40 0.117 ns  1.83 0.038  2.18 0.132 ns  2.57 0.054  2.99 0.146 ns 
C18:1c12 0.25 0.013  0.31 0.031 ns  0.45 0.027  0.49 0.032 ns  0.40 0.027  0.34 0.028 ns 
C18:1c13 0.07 0.007  0.11 0.011 *  0.14 0.008  0.22 0.021 *  0.30 0.021  0.42 0.042 ns 
C18:1c14+t16 0.10 0.010  0.12 0.009 ns  0.32 0.008  0.27 0.027 ns  0.20 0.015  0.15 0.013 * 
C18:1c15 0.05 0.004  0.06 0.004 ns  0.08 0.004  0.09 0.003 ns  0.10 0.018  0.09 0.006 ns 
C18:2n-6 15.2 0.704  15.2 0.674 ns  9.48 1.34  10.7 0.775 ns  7.18 1.15  7.35 0.684 ns 
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C20:0 0.06 0.004  0.06 0.004 ns  0.14 0.011  0.11 0.010 ns  0.08 0.009  0.07 0.007 ns 
C18:3n-3 1.18 0.100  0.87 0.032 *  0.76 0.047  0.61 0.040 *  0.59 0.048  0.39 0.034 * 
C20:1c11 0.08 0.005  0.09 0.010 ns  0.16 0.013  0.21 0.018 ns  0.20 0.015  0.19 0.024 ns 
C18:2c9t11 0.42 0.039  0.48 0.061 ns  0.35 0.031  0.43 0.042 ns  0.49 0.062  0.47 0.051 ns 
C18:4n-3 0.06 0.006  0.05 0.003 ns  nd nd  nd nd -  nd nd  nd nd - 
C20:2n-6 0.31 0.031  0.27 0.033 ns  0.06 0.006  0.07 0.002 ns  0.07 0.017  0.07 0.010 ns 
C22:0 2.98 0.539  2.76 0.306 ns  0.22 0.067  0.22 0.034 ns  0.34 0.102  0.32 0.058 ns 
C20:3n-6 nd nd  nd nd -  0.05 0.005  0.05 0.003 ns  nd nd  nd nd - 
C20:3n-3 0.08 0.004  0.07 0.011 ns  0.04 0.006  0.05 0.003 ns  nd nd  nd nd - 
C20:4n-6 9.65 0.227  9.68 0.498 ns  2.81 0.680  3.04 0.240 ns  2.24 0.727  2.25 0.366 ns 
C20:5n-3 0.40 0.035  0.34 0.023 ns  0.18 0.042  0.13 0.015 ns  0.11 0.031  0.09 0.015 ns 
C22:4n-6 2.50 0.224  2.41 0.304 ns  0.19 0.038  0.27 0.019 ns  0.31 0.094  0.31 0.048 ns 
C22:5n-6 0.52 0.066  0.56 0.067 ns  0.04 0.008  0.06 0.006 ns  0.06 0.018  0.09 0.021 ns 
C22:5n-3 3.59 0.080  2.83 0.223 *  0.52 0.106  0.49 0.046 ns  0.46 0.132  0.36 0.060 ns 
C22:6n-3 1.25 0.146  0.99 0.105 ns  0.07 0.013  0.08 0.008 ns  0.09 0.023  0.08 0.027 ns 
Others 3.12 0.044  3.19 0.249 ns  2.49 0.167  2.72 0.192 ns  3.34 0.447  3.01 0.053 ns 
Fatty acid partial sums                    
∑ SFA 42.8 0.265  42.5 0.400 ns  45.4 2.32  41.5 1.74 ns  36.3 1.46  35.0 0.434 ns 
∑ cis MUFA 11.9 0.258  12.9 1.42 ns  30.3 0.647  32.7 1.59 ns  40.2 1.97  42.2 1.25 ns 
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∑ TFA 2.17 0.175  2.60 0.144 ns  4.63 0.134  4.74 0.165 ns  4.64 0.242  4.72 0.199 ns 
∑ PUFA 34.7 0.608  33.2 1.50 ns  14.2 2.27  15.5 1.03 ns  11.1 2.19  11.0 1.20 ns 
∑ n-6 PUFA 28.1 0.407  28.1 1.28 ns  12.6 2.062  14.2 0.940 ns  9.86 1.97  10.1 1.10 ns 
∑ n-3 PUFA 6.50 0.256  5.10 0.274 **  1.58 0.214  1.36 0.097 ns  1.25 0.221  0.93 0.112 ns 
∑ n-6 LC-PUFA 13.0 0.334  12.9 0.812 ns  3.14 0.727  3.48 0.257 ns  2.68 0.851  2.72 0.432 ns 
∑ n-3 LC-PUFA 5.33 0.228  4.23 0.278 *  0.81 0.167  0.75 0.069 ns  0.66 0.175  0.54 0.094 ns 
∑ DMA 1.29 0.089  1.43 0.135 ns  1.11 0.231  1.29 0.154 ns  2.66 0.850  2.56 0.394 ns 
∑ BCFA 1.06 0.122  0.88 0.051 ns  1.93 0.141  1.39 0.072 *  1.51 0.084  1.06 0.039 ** 
Fatty acid ratios                    
PUFA/SFA 0.81 0.016  0.78 0.040 ns  0.32 0.073  0.38 0.036 ns  0.31 0.073  0.32 0.036 ns 
n-6/n-3 4.34 0.148  5.53 0.181 **  7.95 0.261  10.4 0.264 ***  7.76 0.237  10.9 0.611 ** 
Data are means ± standard error (SE). SFA = ∑ C14:0, C16:0, C18:0, C20:0 and C22:0; cis MUFA = ∑ C14:1c9, C16:1c7, C16:1c9, C18:1c9, C18:1c12, C18:1c13, C18:1c15 and C20:1c11; TFA = ∑ 494 
C18:1t6+t8-, C18:1t9, C18:1t10, C18:1t11, C18:1c11+t15, C18:1t12, C18:1c14+t16 and C18:2c9t11; PUFA = ∑ C18:2n-6, C18:3n-3, C18:4n-3, C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C20:5n-3, 495 
C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3; n-6 PUFA = ∑ C18:2n-6, C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C22:4n-6 and C22:5n-6; n-3 PUFA = ∑ C18:3n-3, C18:4n-3, C20:3n-3, C20:5n-3, 496 
C22:5n-3 and C22:6n-3; n-6 LC-PUFA = n-6 long chain-PUFA = ∑ C20:2n-6, C20:3n-6, C20:3n-3, C20:4n-6, C22:4n-6 and C22:5n-6; n-3 LC-PUFA = n-3 long chain-PUFA = ∑ C20:3n-3, C20:5n-497 
3, C22:5n-3 and C22:6n-3; DMA = dimethylacetals = ∑ DMA-C16:0, DMA-C18:0 and DMA-C18:1; BCFA = branched chain fatty acids = ∑ i-C15:0, a-C15:0, i-C16:0, i-C17:0 and a-C17:0. 498 
499 
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Table 4. Conjugated linoleic acid (CLA) content (mg/100 g tissue) and isomeric distribution (% CLA) of beef brain, heart and kidney from Barrosã bulls fed high (HS) or low 500 
silage (LS) diets. 501 
 502 
 Brain  Heart  Kidney 
 HS  LS   HS  LS   HS  LS  
 Mean SE  Mean SE P value  Mean SE  Mean SE P value  Mean SE  Mean SE P value 
Total CLA+ 1.56 0.258  1.23 0.137 ns  2.59 0.447  2.36 0.219 ns  10.5 1.20  10.5 1.90 ns 
CLA profile                     
t12,t14 1.65 0.380  0.92 0.195 ns  1.43 0.127  1.15 0.144 ns  0.87 0.199  0.67 0.079 ns 
t11,t13 2.77 0.113  3.04 0.128 ns  3.85 0.182  2.17 0.161 ***  2.36 0.145  1.50 0.121 ** 
t10,t12 0.36 0.039  0.44 0.055 ns  1.06 0.094  0.95 0.151 ns  0.23 0.060  0.32 0.035 ns 
t9,t11 2.80 0.107  3.13 0.266 ns  1.66 0.166  1.90 0.190 ns  3.11 0.740  3.67 0.847 ns 
t8,t7 0.90 0.093  0.71 0.139 ns  0.28 0.082  0.30 0.076 ns  0.24 0.026  0.38 0.056 ns 
t7,t9 2.17 0.278  1.75 0.126 ns  1.21 0.317  0.78 0.165 ns  1.36 0.275  1.09 0.284 ns 
t6,t8 0.66 0.384  1.34 0.095 ns  0.97 0.334  0.81 0.225 ns  0.43 0.134  0.59 0.071 ns 
c/t12,14 1.25 0.099  1.48 0.096 ns  0.58 0.043  0.75 0.042 *  0.38 0.090  0.32 0.030 ns 
t11,c13 20.0 1.04  19.7 0.244 ns  3.52 0.268  2.11 0.205 **  1.04 0.042  0.67 0.083 ** 
c11,t13 2.15 0.088  2.08 0.166 ns  2.00 0.157  1.95 0.090 ns  0.99 0.017  1.10 0.101 ns 
t10,c12++ n.d. -  n.d. - -  1.12 0.075  1.31 0.187 ns  0.62 0.076  0.89 0.073 * 
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c9,t11+++ 61.9 0.780  62.1 0.691 ns  78.3 1.35  81.9 1.05 ns  84.2 1.05  84.1 1.29 ns 
t7,c9 3.47 0.035  3.23 0.153 ns  4.00 0.547  4.00 0.440 ns  4.32 0.303  4.73 0.367 ns 
Partial sums                    
Total trans,trans 11.3 0.454  11.3 0.688 ns  10.5 0.541  8.0 0.627 *  8.49 0.879  8.22 1.233 ns 
Total cis/trans 88.7 0.454  88.7 0.688 ns  89.5 0.541  92.0 0.627 *  91.5 0.879  91.8 1.23 ns 
 Liver  Pancreas  Tongue 
 HS  LS   HS  LS   HS  LS  
 Mean SE  Mean SE P value  Mean SE  Mean SE P value  Mean SE  Mean SE P value 
Total CLA+ 9.40 1.10  9.34 1.73 ns  10.9 2.16  11.6 1.26 ns  15.1 6.19  11.9 3.01 ns 
CLA profile                     
t12,t14 0.87 0.199  0.67 0.079 ns  1.05 0.080  0.68 0.080 *  0.65 0.037  0.56 0.053 ns 
t11,t13 2.36 0.145  1.50 0.121 **  2.30 0.315  1.05 0.181 *  0.96 0.118  0.62 0.074 ns 
t10,t12 0.23 0.060  0.32 0.035 ns  0.59 0.120  0.52 0.076 ns  0.37 0.053  0.33 0.037 ns 
t9,t11 3.11 0.740  3.67 0.847 ns  1.75 0.226  1.84 0.292 ns  1.12 0.122  1.06 0.081 ns 
t8,t7 0.24 0.026  0.38 0.056 ns  0.65 0.061  0.43 0.078 ns  0.42 0.064  0.32 0.040 ns 
t7,t9 1.36 0.275  1.09 0.284 ns  0.91 0.163  0.66 0.101 ns  0.86 0.177  0.60 0.069 ns 
t6,t8 0.43 0.134  0.59 0.071 ns  0.75 0.055  0.48 0.108 ns  0.53 0.068  0.27 0.050 * 
c/t12,14 0.38 0.090  0.32 0.030 ns  0.56 0.044  0.47 0.044 ns  0.68 0.064  0.99 0.143 ns 
t11,c13 1.04 0.042  0.67 0.083 **  2.05 0.302  1.05 0.065 *  2.38 0.129  2.33 0.114 ns 
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c11,t13 0.99 0.017  1.10 0.101 ns  1.03 0.158  1.11 0.052 ns  0.68 0.152  1.02 0.132 ns 
t10,c12 0.62 0.076  0.89 0.073 *  0.67 0.096  0.89 0.111 ns  1.27 0.243  1.71 0.331 ns 
c9,t11+++ 84.2 1.05  84.1 1.29 ns  81.4 1.02  84.2 1.05 ns  83.8 0.837  83.4 0.955 ns 
t7,c9 4.32 0.303  4.73 0.367 ns  6.31 0.234  6.71 0.713 ns  6.28 0.286  6.78 0.508 ns 
Partial sums                    
Total trans,trans 8.49 0.879  8.22 1.23 ns  8.00 0.875  5.56 0.475 ns  4.92 0.537  3.74 0.261 ns 
Total cis/trans 91.5 0.879  91.8 1.23 ns  92.0 0.875  94.4 0.475 ns  95.1 0.537  96.3 0.261 ns 
+ Total CLA was determined by the combination of GC-FID and Ag+-HPLC techniques, as described in the text. 503 
++ In brain and kidney samples, this minor CLA isomer co-eluted with the major c9,t11 isomer. 504 
+++ This CLA isomer co-eluted with minor amounts of the t9,c11 isomer. 505 
n.d., not detected. 506 
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Table 5. Loadings for the first two principal components1. 507 
 508 
Variable PC1 PC2 
C14:0 -0.591 0.743 
C14:1c9 -0.394 0.427 
i-C15:0 -0.785 -0.259 
a-C15:0 -0.753 -0.253 
C15:0 -0.745 0.250 
DMA-C16:0 0.389 -0.210 
i-C16:0 -0.689 0.001 
C16:0 -0.314 0.852 
C16:1t9 0.089 -0.130 
i-C17:0 -0.897 0.027 
C16:1c7 0.379 0.552 
C16:1c9 -0.624 0.661 
a-C17:0 -0.959 0.112 
C17:0 -0.686 -0.239 
DMA-C18:0 0.684 0.008 
DMA-C18:1 0.901 0.253 
C18:0 -0.069 -0.657 
C18:1t6-t8 -0.703 0.273 
C18:1t9 -0.820 0.488 
C18:1t10 -0.692 0.376 
C18:1t11 -0.854 -0.199 
C18:1t12 0.383 -0.398 
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C18:1c9 -0.391 0.870 
C18:1c11+t15 0.664 0.577 
C18:1c12 0.037 0.030 
C18:1c13 -0.187 0.799 
C18:1t16+c14 -0.738 0.322 
C18:1c15 -0.818 0.230 
C18:2n-6 -0.207 -0.634 
C20:0 0.363 0.081 
C18:3n-3 -0.570 -0.714 
C20:1c11 0.841 0.376 
C20:2n-6 -0.027 -0.579 
C22:0 -0.025 -0.823 
C20:3n-6 0.798 0.207 
C20:3n-3 0.158 -0.228 
C20:4n-6 0.285 -0.750 
C20:5n-3 0.941 0.073 
C22:4n-6 0.773 -0.101 
C22:5n-6 0.836 0.158 
C22:5n-3 -0.155 -0.841 
C22:6n-3 0.855 0.235 
t12,t14 -0.704 -0.256 
t11,t13 -0.556 -0.627 
t10,t12 -0.735 -0.010 
t9,t11 -0.419 -0.586 
t8,t10 -0.779 0.126 
38 
 
t7,t9 -0.454 -0.443 
t6,t8 -0.584 -0.258 
c/t12,14 -0.666 0.413 
t11,c13 0.013 0.279 
c11,t13 -0.639 -0.230 
t10,c12 -0.626 0.229 
c9,t11 -0.815 -0.080 
t7,c9 -0.781 0.135 
   Proportion of variance (%) 38.96 19.19 
Cumulative variance (%) 38.96 58.15 
1PC: principal component 509 
